Literature DB >> 11096324

Anaphylactoid reaction induced by a protease inhibitor, nafamostat mesilate, following nine administrations in a hemodialysis patient.

N Higuchi, H Yamazaki, H Kikuchi, F Gejyo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11096324     DOI： 10.1159/000045822

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  11 in total

Review 1.  Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

Authors:  H M Oudemans-van Straaten; J P J Wester; A C J M de Pont; M R C Schetz
Journal:  Intensive Care Med       Date:  2006-02-02       Impact factor: 17.440

2.  Consensus of primary care in acute pancreatitis in Japan.

Authors:  Makoto Otsuki; Masahiko Hirota; Shinju Arata; Masaru Koizumi; Shigeyuki Kawa; Terumi Kamisawa; Kazunori Takeda; Toshihiko Mayumi; Motoji Kitagawa; Tetsuhide Ito; Kazuo Inui; Tooru Shimosegawa; Shigeki Tanaka; Keisho Kataoka; Hiromitsu Saisho; Kazuichi Okazaki; Yosikazu Kuroda; Norio Sawabu; Yoshifumi Takeyama
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  J Intensive Care       Date:  2018-08-13

4.  Screening strategy of TMPRSS2 inhibitors by FRET-based enzymatic activity for TMPRSS2-based cancer and COVID-19 treatment.

Authors:  Yeh Chen; Wei-Chien Huang; Chia-Shin Yang; Fang-Ju Cheng; Yi-Fang Chiu; Hsiao-Fan Chen; Thanh Kieu Huynh; Chih-Feng Huang; Chia-Hung Chen; Hsueh-Chun Wang; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

Review 5.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

6.  Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma.

Authors:  Tamotsu Ishizuka; Takeshi Hisada; Motoaki Hatori; Akio Koike; Kikuo Hanabuchi; Shinichi Matsuzaki; Yosuke Kamide; Mitsuyoshi Utsugi; Haruka Aoki; Reiko Yoshino; Noriko Yanagitani; Yasuhiko Koga; Akihiro Ono; Kyoichi Kaira; Noriaki Sunaga; Kunio Dobashi; Takahiro Tsuburai; Kazuo Akiyama; Masanobu Yamada; Kazuhiro Suzuki; Masatomo Mori
Journal:  Inflamm Res       Date:  2014-07-08       Impact factor: 4.575

7.  Fatal anaphylaxis Due to Nafamostat Mesylate During Hemodialysis.

Authors:  Joo Hee Kim; Ji Young Park; Seung Hun Jang; Jwa Kyung Kim; Young Rim Song; Hyung Seok Lee; Sung Gyun Kim
Journal:  Allergy Asthma Immunol Res       Date:  2021-05       Impact factor: 5.764

8.  Anaphylactic Reactions Caused by Nafamostat Mesylate during Hemodialysis before Surgery for Carpal Tunnel Syndrome.

Authors:  Yuta Nakamura; Kaoru Tada; Masashi Matsuta; Atsuro Murai; Hiroyuki Tsuchiya
Journal:  Case Rep Nephrol       Date:  2021-12-29

9.  Ability of nafamostat mesilate to prolong filter patency during continuous renal replacement therapy in patients at high risk of bleeding: a randomized controlled study.

Authors:  Yong Kyu Lee; Hae Won Lee; Kyu Hun Choi; Beom Seok Kim
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

10.  Cardiac arrest caused by nafamostat mesilate.

Authors:  Hyo Shik Kim; Kyung Eun Lee; Ji Hyun Oh; Chan Sung Jung; Dughyun Choi; Yunsuek Kim; Jin Seok Jeon; Dong Cheol Han; Hyunjin Noh
Journal:  Kidney Res Clin Pract       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.